Business Description
Founded in 2009 and based in Cambridge, UK, Bicycle Therapeutics is a clinical-stage drug developer working on a new category of precision medicines designed to treat cancers and other serious conditions that current therapies struggle to address. The company has built a pipeline of targeted treatments, including several compounds in active clinical trials aimed at specific tumor types, as well as early-stage programs focused on neurological and neuromuscular diseases. Bicycle Therapeutics works alongside a number of established pharmaceutical companies, including Novartis, AstraZeneca, Bayer, Ionis Pharmaceuticals, and Genentech, to advance treatments across multiple disease areas.
